News & Analysis on Clinical Trial Services & Contract Research And Development
Scientists may be fighting a losing battle to develop alternative treatments to drug resistant pathogens, as research reveals the evolution of drug resistance in bacteria is a trait that is favoured through the process of natural selection.
Calling the next six months 'a critical period', the US Food and Drug Administration's Acting Commissioner Lester Crawford has unveiled a lengthy list of agency priorities, including continued work on Good Manufacturing Practice (GMP) standards.
Genes, which are linked to either resistance or sensitivity to four major cancer drugs used to treat acute lymphoblastic leukaemia (ALL) has led to the suggestion that these genes determine treatment outcome and may represent future molecular targets.
Building on a stronger start to the year, Germany's third largest chemicals group reports continued growth into the second quarter with an increase in demand pushing up sales and earnings.
Solvay Chemicals has said that it will increase off-list prices for all grades of hydrogen peroxide (H2O2) in North America from 15 September in the face of escalating demand.
Cobra Biomanufacturing has received approval from the UK regulatory authorities for its new clinical trial manufacturing facilities in Oxford as well as its established unit in Keele.